PT  - JOURNAL ARTICLE
AU  - P. Magal
AU  - G. Webb
TI  - Predicting the number of reported and unreported cases for the COVID-19 epidemic in South Korea, Italy, France and Germany
AID  - 10.1101/2020.03.21.20040154
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.21.20040154
4099  - http://medrxiv.org/content/early/2020/03/24/2020.03.21.20040154.short
4100  - http://medrxiv.org/content/early/2020/03/24/2020.03.21.20040154.full
AB  - We model the COVID-19 coronavirus epidemic in South Korea, Italy, France, and Germany. We use early reported case data to predict the cumulative number of reported cases to a final size. The key features of our model are the timing of implementation of major public policies restricting social movement, the identification and isolation of unreported cases, and the impact of asymptomatic infectious cases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundingAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe Data are coming from WHO.